EDGAR Filing Documents for 0001558370-23-002746

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001558370-23-002746

Filing Date

2023-03-03

Accepted

2023-03-03 08:16:06

Documents

122

Period of Report

2022-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	kala-20221231x10k.htm iXBRL	10-K	3893577
2	EX-3.1	kala-20221231xex3d1.htm	EX-3.1	176006
3	EX-4.1	kala-20221231xex4d1.htm	EX-4.1	3848
4	EX-4.3	kala-20221231xex4d3.htm	EX-4.3	24180
5	EX-4.5	kala-20221231xex4d5.htm	EX-4.5	136371
6	EX-21.1	kala-20221231xex21d1.htm	EX-21.1	5250
7	EX-23.1	kala-20221231xex23d1.htm	EX-23.1	2699
8	EX-31.1	kala-20221231xex31d1.htm	EX-31.1	8964
9	EX-31.2	kala-20221231xex31d2.htm	EX-31.2	8935
10	EX-32.1	kala-20221231xex32d1.htm	EX-32.1	5204
11	EX-32.2	kala-20221231xex32d2.htm	EX-32.2	6125
12	EX-99.1	kala-20221231xex99d1.htm	EX-99.1	112941
13	GRAPHIC	kala-20221231x10k006.jpg	GRAPHIC	54970
14	GRAPHIC	kala-20221231x10k007.jpg	GRAPHIC	65834
15	GRAPHIC	kala-20221231x10k008.jpg	GRAPHIC	35606
16	GRAPHIC	kala-20221231x10k009.jpg	GRAPHIC	20097
17	GRAPHIC	kala-20221231x10k010.jpg	GRAPHIC	45242
18	GRAPHIC	kala-20221231x10k011.jpg	GRAPHIC	28954
19	GRAPHIC	kala-20221231x10k012.jpg	GRAPHIC	44551
20	GRAPHIC	kala-20221231xex4d1g001.jpg	GRAPHIC	288458
21	GRAPHIC	kala-20221231xex4d1g002.jpg	GRAPHIC	83048
	Complete submission text file	0001558370-23-002746.txt		15612491

Data Files

Seq	Description	Document	Type	Size
22	EX-101.SCH	kala-20221231.xsd	EX-101.SCH	94868
23	EX-101.CAL	kala-20221231_cal.xml	EX-101.CAL	89003
24	EX-101.DEF	kala-20221231_def.xml	EX-101.DEF	476050
25	EX-101.LAB	kala-20221231_lab.xml	EX-101.LAB	821268
26	EX-101.PRE	kala-20221231_pre.xml	EX-101.PRE	682399
116	EXTRACTED XBRL INSTANCE DOCUMENT	kala-20221231x10k_htm.xml	XML	2164625

Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476

Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252

Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)